Anavex Life Sciences Corp (AVXL)

[BAR123]

So we only have 1 trial currently running and that is the OLE Alz trial https://www.clinicaltrials.gov/search?term=anavex&limit=25&page=1 Approximately 1 1/2 years ago we were to start the following trials by the end of 2022. Parkinson's Disease Dementia, Parkinson's Disease , Angelman Syndrome, Fragile X, Frontotemporal Dementia and the elusive undisclosed disease. Here we are in late 2023 with zero of the above not being started. The big question is WHY? I would like to think that with all the slips in the past, these guys are not this bad so what could it be. Are we for sale or ready to partner? Does the partner want a say in what trials we/they will run? Maybe the trials have begun but they just haven't updated the clinical trials . gov site to show us what they are doing. My personal take is we are in negotiations which has made the company clam up as to what the strategy is. I think we are very close to knowing a lot more. No company goes this quiet for no reason. Now rest assure that if there was material bad news the company must report it. But why would there be bad news. We hit all end points for every trial we ever did. Something big is happening, but what? I think buyout because a partnership should not be this long to complete and should not stop the PR's like they have. I think it will be in the $8B -$12B range